Skip to main content
. Author manuscript; available in PMC: 2019 Mar 25.
Published in final edited form as: J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Jun 6;901:25–33. doi: 10.1016/j.jchromb.2012.05.036

Figure 4.

Figure 4.

Representative plasma concentration-time profiles of MX in patients. (A) Dosing regimen: MX (iv continuous infusion), 15 mg/m2/day for 5 days; TMZ (oral once daily), 100 mg/m2/day for 5 days. (B) Dosing regimen: MX (single 1-h iv infusion), 15 mg/m2/day; and TMZ (oral once daily), 100 mg/m2/day for 5 days.